MedTrace Logo

Safety Study of VCT-01™ in Split-Thickness Skin Graft Donor Site Wounds

NCT01292122 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2012-12-20

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety of VCT-01 in split-thickness skin graft (STSG) donor site wounds and assess selected parameters of healing at the VCT-01-treated donor site.

Conditions

  • Wounds

Interventions

DEVICE

VCT-01

Application of bi-layered living cell-based product (VCT-01) to STSG donor site wound at Day 0

Sponsors & Collaborators

  • Organogenesis

    lead INDUSTRY

Principal Investigators

  • Edward E Tredget, MD · University of Alberta

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01292122 on ClinicalTrials.gov